Aranesp Clinical Trials Aranesp RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Forearm Blood Flow in Chronic Kidney Disease Subjects With Anemia (FBF-CKD)
Condition:   Anaemia Interventions:   Drug: Daprodustat;   Drug: Darbepoetin alfa (Aranesp);   Drug: Acetylcholine;   Drug: Sodium nitroprusside;   Drug: L-N-monomethyl arginine citrate (L-NMMA) Sponsor:   GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2018 Category: Research Source Type: clinical trials

EPO-4-Rhesus: Role of Darbepoetin Alfa in Reducing Late Anaemia in Neonates With Red Blood Cell Alloimmunization After Intrauterine Transfusions
Conditions:   Erythroblastosis, Fetal;   Erythroblastosis Fetalis, Rh Disease;   Erythroblastosis Fetalis Due to RH Antibodies;   Erythroblastosis Fetalis Due to Isoimmunization Intervention:   Drug: Darbepoetin Alfa Sponsors:   Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research;   Leiden University Medical Center Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2017 Category: Research Source Type: clinical trials